Bertin Pharma Bertin Pharma
Select your search
Contact us
You are here : Focus on Bioreagents and Bioanalytical Tools providing

Focus on Bioreagents and Bioanalytical Tools providing

Bertin Pharma refocus on Bioreagent & Bionalytical Tools providing

August 2017, Bertin Pharma has signed agreement for the sale of its pre-clinical and clinical studies’ activities.

CNIM Group, Bertin Pharma’s main shareholder, decided to focus on strategic axes to be more in tune with its industrial core activities in the fields of energy, environment, defence and security.

Bertin Pharma continues to be your partner for…

Bioreagents and Bioanalytical tools supplier

Bertin Pharma keeps on offering you 20 000 product references for your researches which applications applied to metabolism, cardiovascular diseases, cancer, immunology or inflammation and even more…

Product pipeline & out-licencing

Bertin Pharma proposes new innovative formulations combining safety and comfort of use for the patients.
Based on this know-how, we offer MA dossiers for therapeutics indications in relation with pain, coughs, cold, gastro-intestinal problem or allergies.

Oncodesign : Your new partner for non-clinical and clinical support

Oncodesign, French company, takes over Bertin Pharma's clinical and non-clinical services providing.

This purchase of goodwill is integrated into its strategic development plans.

Oncodesign is a pure player in its field. This dimension, not least, ensures the sustainability and quality of services.


  • Drug Discovery & Translational Research
  • Drug Analysis & Bioanalysis
  • Non Clinical Studies
  • Clinical Studies
  • Biobanking
  • Biosafety
  • Biocidal activity & biodecontamination

Contact Oncodesign

Read Press Release in French

Read Press Release in English

About Oncodesign

Oncodesign is a biotechnology company which maximises the opportunities of the pharma industries to discover new therapeutic molecules against cancers and other serious diseases without effective treatment to date.

Based on both a unique experience with more than 600 clients, including the world's largest pharmaceutical companies, and a complete technological platform combining medical chemistry, pharmacology and advanced medical imaging, Oncodesign is able to predict and to identify, very upstream, for each molecule its therapeutic use and its potential to become an effective drug.

Headquartered in Dijon, at the heart of the university and hospitals cluster and within the Paris-Saclay cluster, Oncodesign has 165 employees and subsidiaries in Canada and the United States.


Bertin Pharma - Institutionnel

Follow Us

Linkedin Youtube Twitter Google+

Contact us

Any project? Any challenge? We are in!
+33 (0) 139 306 260
Any questions? Contact us

Parc d’Activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux - France
View our other locations


Do you want to be kept updated with Bertin Pharma's latest news?

Manage my subscriptions